Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
The song “Donnie Darko” by Let’s Eat Grandma was on repeat during the making of this Readout.
The need-to-know this morning
-
Bristol Myers Squibb has made changes to its R&D structure. Current Chief Medical Officer Cristian Massacesi has been given the additional title of head of R&D. Robert Plenge, Bristol’s chief of research, will depart the company in March.
- The FDA has shelved the Commissioner’s National Priority Voucher program, according to Reuters.
Heidi Overton’s FDA nomination faces a tight vote
The Senate health committee will vote next Wednesday on Heidi Overton’s nomination to lead the FDA, and Republicans still aren’t all on board. Committee Chair Bill Cassidy of Louisiana says he’s undecided and has called Overton’s role in shaping the Trump administration’s vaccine policies “almost disqualifying,” STAT’s Margaret Manto writes. A single Republican defection could sink the nomination if every Democrat votes against her.
Continue to STAT+ to read the full story…
